152 related articles for article (PubMed ID: 12648796)
21. The influence of the IAEA standard holder on dose evaluated from TLD samples.
Izewska J; Novotny J; Van Dam J; Dutreix A; van der Schueren E
Phys Med Biol; 1996 Mar; 41(3):465-73. PubMed ID: 8778826
[TBL] [Abstract][Full Text] [Related]
22. Mailed TL dosimetry programme for machine output check and clinical application in the EORTC radiotherapy group.
Hansson U; Johansson KA; Horiot JC; Bernier J
Radiother Oncol; 1993 Nov; 29(2):85-90. PubMed ID: 8310158
[TBL] [Abstract][Full Text] [Related]
23. Testing the methodology for dosimetry audit of heterogeneity corrections and small MLC-shaped fields: Results of IAEA multi-center studies.
Izewska J; Wesolowska P; Azangwe G; Followill DS; Thwaites DI; Arib M; Stefanic A; Viegas C; Suming L; Ekendahl D; Bulski W; Georg D
Acta Oncol; 2016 Jul; 55(7):909-16. PubMed ID: 26934916
[TBL] [Abstract][Full Text] [Related]
24. Influence of phantom materials on the energy dependence of LiF:Mg,Ti thermoluminescent dosimeters exposed to 20-300 kV narrow x-ray spectra, 137Cs and 60Co photons.
Massillon-J L G; Cabrera-Santiago A; Minniti R; O'Brien M; Soares CG
Phys Med Biol; 2014 Aug; 59(15):4149-66. PubMed ID: 25004055
[TBL] [Abstract][Full Text] [Related]
25. Determination of absorbed dose to water around a clinical HDR (192)Ir source using LiF:Mg,Ti TLDs demonstrates an LET dependence of detector response.
Carlsson Tedgren A; Elia R; Hedtjarn H; Olsson S; Alm Carlsson G
Med Phys; 2012 Feb; 39(2):1133-40. PubMed ID: 22320824
[TBL] [Abstract][Full Text] [Related]
26. [Development of external quality control protocol for CyberKnife beams dosimetry: preliminary tests multicentre].
Guinement L; Marchesi V; Veres A; Lacornerie T; Buchheit I; Peiffert D
Cancer Radiother; 2013; 17(4):288-96. PubMed ID: 23871458
[TBL] [Abstract][Full Text] [Related]
27. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer.
Bentzen SM; Bernier J; Davis JB; Horiot JC; Garavaglia G; Chavaudra J; Johansson KA; Bolla M
Eur J Cancer; 2000 Mar; 36(5):615-20. PubMed ID: 10738126
[TBL] [Abstract][Full Text] [Related]
29. Uncertainty analysis of absorbed dose calculations from thermoluminescence dosimeters.
Kirby TH; Hanson WF; Johnston DA
Med Phys; 1992; 19(6):1427-33. PubMed ID: 1461205
[TBL] [Abstract][Full Text] [Related]
30. The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial.
Venables K; Miles EA; Aird EG; Hoskin PJ;
Radiother Oncol; 2004 Jun; 71(3):303-10. PubMed ID: 15172146
[TBL] [Abstract][Full Text] [Related]
31. Assessment of national dosimetry quality audits results for teletherapy machines from 1989 to 2015.
Muhammad W; Ullah A; Mahmood K; Matiullah
J Appl Clin Med Phys; 2016; 17(2):145-152. PubMed ID: 27538269
[TBL] [Abstract][Full Text] [Related]
32. Monte Carlo simulation of correction factors for IAEA TLD holders.
Hultqvist M; Fernández-Varea JM; Izewska J
Phys Med Biol; 2010 Mar; 55(6):N161-6. PubMed ID: 20197601
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric inter-institutional comparison in European radiotherapy centres: Results of IAEA supported treatment planning system audit.
Gershkevitsh E; Pesznyak C; Petrovic B; Grezdo J; Chelminski K; do Carmo Lopes M; Izewska J; Van Dyk J
Acta Oncol; 2014 May; 53(5):628-36. PubMed ID: 24164104
[TBL] [Abstract][Full Text] [Related]
34. The IAEA/WHO TLD postal dose quality audits for radiotherapy: a perspective of dosimetry practices at hospitals in developing countries.
Izewska J; Andreo P; Vatnitsky S; Shortt KR
Radiother Oncol; 2003 Oct; 69(1):91-7. PubMed ID: 14597361
[TBL] [Abstract][Full Text] [Related]
35. The 1998 Australian external beam radiotherapy survey and IAEA/WHO TLD postal dose quality audit.
Huntley R; Izewska J
Australas Phys Eng Sci Med; 2000 Mar; 23(1):21-9. PubMed ID: 10921198
[TBL] [Abstract][Full Text] [Related]
36. Optimum parameters of TLD100 powder used for radiotherapy beams calibration check.
Arib M; Yaich A; Messadi A; Dari F
Med Dosim; 2006; 31(3):184-9. PubMed ID: 16905448
[TBL] [Abstract][Full Text] [Related]
37. IAEA/WHO TLD postal dose audit service and high precision measurements for radiotherapy level dosimetry. International Atomic Energy Agency/World Health Organization.
Izewska J; Bera P; Vatnitsky S
Radiat Prot Dosimetry; 2002; 101(1-4):387-92. PubMed ID: 12382774
[TBL] [Abstract][Full Text] [Related]
38. Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.
Schiefer H; Buchauer K; Heinze S; Henke G; Plasswilm L
Strahlenther Onkol; 2015 Nov; 191(11):855-61. PubMed ID: 26087907
[TBL] [Abstract][Full Text] [Related]
39. The quality of dental radiography in the Czech Republic--results of a TLD and film postal audit.
Novák L
Radiat Prot Dosimetry; 2006; 120(1-4):155-8. PubMed ID: 16782748
[TBL] [Abstract][Full Text] [Related]
40. Quality assurance of serial tomotherapy for head and neck patient treatments.
Low DA; Chao KS; Mutic S; Gerber RL; Perez CA; Purdy JA
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):681-92. PubMed ID: 9806530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
